Understanding Immune Checkpoint Blockade: A Pillar of Modern Cancer Treatment

Welcome to the world of immune checkpoint blockade !

This course has been designed to provide you with a basic understanding of immune checkpoint blockade therapy, a revolutionary treatment approach involving therapeutic monoclonal antibodies, which harnesses the patient’s own immune system to attack their cancer, and that has already transformed how we treat the disease. In the course you will find out about:

The impact of checkpoint blockade therapies in the clinic across different cancer types
The science underpinning the therapeutic responses
The challenges in implementation from both a clinical and scientific perspective
Potential biomarkers of treatment response
Immune-related toxicity that can sometimes result from treatment, and how we might limit these
The lack of responses for some cancers/patient groups
Future developments that are being researched to optimise the approach

Important: To access the course content, click the activities button located near the bottom of this page. This will direct you to a list of relevant materials that you can work through at your own pace. If you join us to study at post-graduate level, this short course will be added to your transcript under 'Additional Awards'.